137 results
Page 3 of 7
6-K
EX-99
klskyytu z691
3 Jun 20
Current report (foreign)
8:30am
424B5
cs6pvrizhdr oazm
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
dp5t zxad4
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
ff32oftpd
28 Jun 19
BioLineRx Announces Change in Ratio of American
4:01pm
20-F/A
07mojs266g mg
5 Jun 19
Annual report (foreign) (amended)
7:00am
6-K
EX-99
re6na7 dn
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
x3wlr4yyo
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
qo2bxvt7s2k83qcji
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
yn8z jyxhvzk5x8nal
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-99.2
tu2 87ag02r5
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-10.3
2uyskzqo
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am